<DOC>
	<DOCNO>NCT02023125</DOCNO>
	<brief_summary>This two-group study investigate effect food ( Group 1 ) esomeprazole ( Group 2 ) single oral dose pharmacokinetics alectinib healthy volunteer . Participants Group 1 randomly assign two period treatment sequence ( AB BA ) receive single , oral dose alectinib per period separate least 10 day . Each participant receive single , oral dos alectinib give fast condition ( Treatment A ) follow ingestion high fat , high calorie meal ( Treatment B ) determine assigned sequence . Participants Group 2 give single , oral dose alectinib follow standard meal . After washout period least 10 day , receive oral dose esomeprazole ( 40 mg ) daily 6 day . On 6th day esomeprazole administration , single , oral dose alectinib give ingestion standard meal . In group , pharmacokinetics assess 4 day follow alectinib administration .</brief_summary>
	<brief_title>A Study Investigating Effect Food Esomeprazole Single Oral Dose Pharmacokinetics Alectinib ( RO5424802 ) Healthy Volunteers .</brief_title>
	<detailed_description />
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Body mass index ( BMI ) 18 32 kilogram per square meter ( kg/m^2 ) Healthy male female participant . Healthy status define absence evidence active chronic disease follow detailed medical surgical history , complete physical examination include vital sign , 12lead electrocardiogram ( ECG ) , hematology , blood chemistry , serology urinalysis Female participant must surgically sterile postmenopausal past year confirm blood follicle stimulate hormone ( FSH ) test female without hormone replacement therapy ( HRT ) Male participant must willing use effective contraception , define protocol , throughout study 3 month last drug administration Willing abstain xanthinecontaining beverage food ( coffee , tea , cola , chocolate , `` energy drink '' ) use 72 hour prior admission study clinic discharge Willing abstain consume grapefruit , pomelo , star fruit , Seville orange contain product 7 day prior first dose study medication discharge Willing avoid prolong sun exposure take alectinib followup . Participants also advise use broad spectrum sun screen lip balm least sun protection factor ( SPF ) &gt; 30 help protect potential sunburn Group 2 participant H. Pylori negative via breath test Pregnant breastfeeding woman , male female partner pregnant breastfeeding , woman childbearing potential . Positive test drug abuse , alcohol cotinine test screen prior admission study unit Suspicion regular consumption drug ( ) abuse include marijuana . Current smoker participant discontinue smoke less six month prior first dose . Participants avoid smoky environment least 1 week prior cotinine test History ( within 3 month screen ) alcohol consumption exceed 2 standard drink per day average ( 1 standard drink = 10 gram alcohol ) . Alcohol consumption prohibit 72 hour prior admission study clinic throughout entire study discharge Participants risk factor family history QT/QTcF prolongation ECG abnormalities abnormality ECG , opinion investigator , increase risk participate study Confirmed systolic blood pressure ( SBP ) great 140 millimeter mercury ( mmHg ) less 90 mmHg diastolic blood pressure ( DBP ) great 90 mmHg less 45 mmHg screening , admission study center prior dose . Notable rest bradycardia ( mean pulse rate &lt; 45 beat per minute [ bpm ] ) tachycardia ( mean pulse rate &gt; 90 bpm ) Use medication ( prescription overthecounter ) within 2 week 5 halflives ( whichever longer ) first dose study medication exception acetaminophen 2 g per day 48 hour prior dose , exceed 4 g total week prior dose Use herbal supplement metabolic inducer within 4 week 5 halflives ( whichever longer ) first dose study medication , include limited follow drug : rifampin , rifabutin , glucocorticoid , carbamazepine , phenytoin phenobarbital Strenuous activity , sunbathe contact sport allow 4 day prior entry clinical site duration study followup Participation investigational drug device study within 45 day 5 halflives ( whichever longer ) 6 month biologic therapy prior first dose Donation blood 450 mL within 45 day prior screen Regular use antacid , Histamine 2 ( H2 ) receptor blocker , proton pump inhibitor ( PPIs ) medication may alter normal gastric environment and/or motility . No use medication within 2 week prior first dose .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>